ID

20821

Beschreibung

This study is a prospective, interventional, open-label, multi-center early access program for the use of Ra-223 Cl2 in HRPC/CRPC (Hormone refractory prostate cancer / Castrate resistant prostate cancer) patients diagnosed with bone metastasis and to collect additional short and long term safety data on the product. NCT01618370

Stichworte

  1. 20.03.17 20.03.17 -
Hochgeladen am

20. März 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Radium-223 Dichloride (Alpharadin) DRKS00006460 NCT01618370 in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases (End of Study Treatment)

Radium 223 Dichloride (Alpharadin) - End of Study Treatment

End of Study Treatment
Beschreibung

End of Study Treatment

Did the subject complete the treatment period?
Beschreibung

treatment period completed

Datentyp

boolean

Alias
UMLS CUI [1]
C2732579
Primary reason for discontinuation of study treatment
Beschreibung

Primary reason for discontinuation of study treatment

Datentyp

text

Alias
UMLS CUI [1,1]
C0008976
UMLS CUI [1,2]
C0457454
UMLS CUI [1,3]
C1549995
If primary reason is "Adverse Event(s) not associated with clinical disease progression", give number(s). Up to 3 AE numbers can be entered:
Beschreibung

Dynamic search /ist contains: "Number - Term - Start Date"

Datentyp

text

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0392360
UMLS CUI [1,3]
C0877248
If primary reason is "Withdrawal by subject (Consent withdrawn)",specify
Beschreibung

primary reason Consent withdrawn

Datentyp

text

Alias
UMLS CUI [1,1]
C1549995
UMLS CUI [1,2]
C1707492
If primary reason is "Other",specify
Beschreibung

If primary reason is "Other",specify

Datentyp

text

Alias
UMLS CUI [1,1]
C1549995
UMLS CUI [1,2]
C0205394
Subject entered active follow-up?
Beschreibung

Subject entered active follow-up?

Datentyp

text

Alias
UMLS CUI [1]
C0589120

Ähnliche Modelle

Radium 223 Dichloride (Alpharadin) - End of Study Treatment

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
End of Study Treatment
treatment period completed
Item
Did the subject complete the treatment period?
boolean
C2732579 (UMLS CUI [1])
Primary reason for discontinuation of study treatment
Item
Primary reason for discontinuation of study treatment
text
C0008976 (UMLS CUI [1,1])
C0457454 (UMLS CUI [1,2])
C1549995 (UMLS CUI [1,3])
primary reason Adverse Event
Item
If primary reason is "Adverse Event(s) not associated with clinical disease progression", give number(s). Up to 3 AE numbers can be entered:
text
C1444662 (UMLS CUI [1,1])
C0392360 (UMLS CUI [1,2])
C0877248 (UMLS CUI [1,3])
primary reason Consent withdrawn
Item
If primary reason is "Withdrawal by subject (Consent withdrawn)",specify
text
C1549995 (UMLS CUI [1,1])
C1707492 (UMLS CUI [1,2])
If primary reason is "Other",specify
Item
If primary reason is "Other",specify
text
C1549995 (UMLS CUI [1,1])
C0205394 (UMLS CUI [1,2])
Subject entered active follow-up?
Item
Subject entered active follow-up?
text
C0589120 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video